Dexamethasone, cerebrospinal fluid matrix metalloproteinase concentrations and clinical outcomes in tuberculous meningitis.

Dexamethasone, cerebrospinal fluid matrix metalloproteinase concentrations and clinical outcomes in tuberculous meningitis.

BACKGROUND: Adjunctive dexamethasone reduces mortality from tuberculous meningitis, but how it produces this effect is not known. Matrix metalloproteinases (MMPs) are important in the immunopathology of many inflammatory CNS diseases thus we hypothesized that that their secretion is important in TBM...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy:	Green, J, Tran, C, Farrar, J, Nguyen, M, Nguyen, P, Dinh, S, Ho, N, Ly, C, Tran, H, Friedland, J, Thwaites, G
Format:	Journal article
Język:	English
Wydane:	Public Library of Science 2009

Podobne zapisy

Dexamethasone for tuberculous meningitis - Reply
od: Thwaites, G, i wsp.
Wydane: (2005)

Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults.
od: Thwaites, G, i wsp.
Wydane: (2004)

Dexamethasone and long-term outcome of tuberculous meningitis in Vietnamese adults and adolescents.
od: Torok, M, i wsp.
Wydane: (2011)

Dexamethasone and long-term outcome of tuberculous meningitis in Vietnamese adults and adolescents.
od: Török, M, i wsp.
Wydane: (2011)

Serial MRI to determine the effect of dexamethasone on the cerebral pathology of tuberculous meningitis: an observational study
od: Thwaites, G, i wsp.
Wydane: (2007)

Serial MRI to determine the effect of dexamethasone on the cerebral pathology of tuberculous meningitis: an observational study.
od: Thwaites, G, i wsp.
Wydane: (2007)

Dexamethasone and long-term outcome of tuberculous meningitis in Vietnamese adults and adolescents.
od: M Estée Török, i wsp.
Wydane: (2011-01-01)

Elevated cerebrospinal fluid cytokine levels in tuberculous meningitis predict survival in response to dexamethasone
od: Whitworth, LJ, i wsp.
Wydane: (2021)

Cerebrospinal fluid matrix metalloproteinase 9 levels, blood-brain barrier permeability, and treatment outcome in tuberculous meningitis.
od: Sharada Mailankody, i wsp.
Wydane: (2017-01-01)

Bacterial DNA Load in Cerebrospinal Fluid During Treatment of Bacterial Meningitis
od: Tran, N, i wsp.
Wydane: (2008)

Dexamethasone in Vietnamese adolescents and adults with bacterial meningitis.
od: Nguyen, T, i wsp.
Wydane: (2007)

CNS infection, CSF matrix metalloproteinase concentrations, and clinical/laboratory features.
od: Green, J, i wsp.
Wydane: (2011)

Proresolving mediator profiles in cerebrospinal fluid are linked with disease severity and outcome in adults with tuberculous meningitis
od: Colas, RA, i wsp.
Wydane: (2019)

Dexamethasone for tuberculous meningitis.
od: Marras, T
Wydane: (2005)

Tuberculous meningitis.
od: Thwaites, G, i wsp.
Wydane: (2000)

Improving the bacteriological diagnosis of tuberculous meningitis.
od: Thwaites, G, i wsp.
Wydane: (2004)

The cerebrospinal fluid cytological features of tuberculous meningitis in children
od: Xiao YANG, i wsp.
Wydane: (2013-02-01)

Characteristics of Cerebrospinal Fluid in Tuberculous Meningitis Patients with Hydrocephalus
od: Astrid Tamara Maajid Budiman, i wsp.
Wydane: (2018-09-01)

The application value of cerebrospinal fluid immunoglobulin in tuberculous meningitis
od: Hua He, i wsp.
Wydane: (2024-06-01)

COMPARATIVE ANALYSIS OF CEREBROSPINAL FLUID ADA LEVELS IN TUBERCULOUS AND NON-TUBERCULOUS MENINGITIS
od: Zahid Ullah, i wsp.
Wydane: (2018-12-01)

Routine Diagnosis of Tuberculous Meningitis with MODS Assay
od: Nguyen, Q, i wsp.
Wydane: (2008)

Cerebrospinal Fluid Amino Acid Profiling of Pediatric Cases with Tuberculous Meningitis
od: Shayne Mason, i wsp.
Wydane: (2017-09-01)

Evaluation of the MODS culture technique for the diagnosis of tuberculous meningitis.
od: Caws, M, i wsp.
Wydane: (2007)

Tuberculous meningitis.
od: Van, T, i wsp.
Wydane: (2014)

Clinical and Cerebrospinal Fluid Abnormalities as Diagnostic Tools of Tuberculous Meningitis
od: Fiona Lestari, i wsp.
Wydane: (2016-03-01)

Cerebrospinal fluid Gene XPERT (CBNAAT) in children with tuberculous meningitis
od: Annapurna Rai, i wsp.
Wydane: (2021-08-01)

Adjunctive dexamethasone for tuberculous meningitis in HIV-positive adult
od: Donovan, J, i wsp.
Wydane: (2023)

Elevated matrix metalloproteinase concentrations offer novel insight into their role in pediatric tuberculous meningitis
od: Li, YJ, i wsp.
Wydane: (2019)

Targeted sequencing from cerebrospinal fluid for rapid identification of drug-resistant tuberculous meningitis
od: Tram, TTB, i wsp.
Wydane: (2024)

The clinical benefit of adjunctive dexamethasone in tuberculous meningitis is not associated with measurable attenuation of peripheral or local immune responses
od: Simmons, C, i wsp.
Wydane: (2005)

The clinical benefit of adjunctive dexamethasone in tuberculous meningitis is not associated with measurable attenuation of peripheral or local immune responses.
od: Simmons, C, i wsp.
Wydane: (2005)

Tuberculous meningitis: many questions, too few answers.
od: Thwaites, G, i wsp.
Wydane: (2005)

Naïve-pooled pharmacokinetic analysis of pyrazinamide, isoniazid and rifampicin in plasma and cerebrospinal fluid of Vietnamese children with tuberculous meningitis
od: Pouplin, T, i wsp.
Wydane: (2016)

Tuberculous meningitis
od: Thwaites, G
Wydane: (2013)

Tuberculous meningitis
od: Thwaites, G
Wydane: (2017)

Study of cerebrospinal fluid adenosine deaminase activity for differential diagnosis of tuberculous and non-tuberculous meningitis
od: Seema Agarwal, i wsp.
Wydane: (2023-12-01)

Systemic and cerebrospinal fluid biomarkers for tuberculous meningitis identification and treatment monitoring
od: Xiang-Ping Yao, i wsp.
Wydane: (2024-01-01)

Cerebrospinal fluid findings of infant tuberculous meningitis: a scoping review
od: Jie Hou, i wsp.
Wydane: (2022-12-01)

Diagnostic Importance of Cerebrospinal Fluid Adenosine Deaminase Levels in Tuberculous Meningitis
od: Harika kolli, i wsp.
Wydane: (2021-10-01)

Pharmacokinetics and pharmacodynamics of intensive antituberculosis treatment of tuberculous meningitis
od: Ding, J, i wsp.
Wydane: (2020)